News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,447 Results
Type
Article (1520)
Company Profile (11)
Press Release (67916)
Section
Business (31354)
Career Advice (53)
Deals (4625)
Drug Delivery (2)
Drug Development (7811)
Employer Resources (9)
FDA (1256)
Job Trends (1693)
News (43300)
Policy (2354)
Tag
Academia (151)
Adcomms (1)
Allergies (10)
Alliances (2436)
ALS (7)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (8)
Approvals (1283)
Artificial intelligence (12)
Autoimmune disease (3)
Automation (2)
Bankruptcy (12)
Best Places to Work (1622)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (12)
Bladder cancer (13)
Brain cancer (2)
Breast cancer (34)
Cancer (322)
Cardiovascular disease (18)
Career advice (49)
Career pathing (1)
CAR-T (12)
Cell therapy (39)
Cervical cancer (3)
Clinical research (6986)
Collaboration (46)
Compensation (24)
Complete response letters (2)
COVID-19 (177)
CRISPR (3)
C-suite (4)
Cystic fibrosis (14)
Data (413)
Depression (5)
Diabetes (25)
Diagnostics (738)
Digital health (2)
Diversity, equity & inclusion (2)
Drug discovery (6)
Drug pricing (3)
Duchenne muscular dystrophy (24)
Earnings (27831)
Employer branding (1)
Employer resources (7)
Events (8197)
Executive appointments (21)
FDA (1476)
Frontotemporal dementia (1)
Funding (47)
Gene editing (10)
Gene therapy (26)
GLP-1 (56)
Government (202)
Guidances (110)
Healthcare (2102)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (9)
Indications (5)
Infectious disease (190)
Inflammatory bowel disease (13)
Influenza (7)
Intellectual property (3)
Interviews (3)
IPO (3452)
IRA (1)
Job creations (175)
Job search strategy (46)
Kidney cancer (2)
Labor market (4)
Layoffs (18)
Leadership (1)
Legal (515)
Liver cancer (3)
Lung cancer (63)
Lymphoma (31)
Management (3)
Manufacturing (13)
MASH (15)
Medical device (1739)
Medtech (1739)
Mergers & acquisitions (1232)
Metabolic disorders (75)
Multiple sclerosis (12)
NASH (2)
Neurodegenerative disease (2)
Neuropsychiatric disorders (3)
Neuroscience (170)
NextGen: Class of 2025 (453)
Non-profit (266)
Obesity (34)
Opinion (4)
Ovarian cancer (7)
Pain (3)
Pancreatic cancer (5)
Parkinson's disease (10)
Partnered (1)
Patents (11)
Patient recruitment (8)
Peanut (7)
People (2251)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1690)
Phase II (2991)
Phase III (2853)
Pipeline (561)
Policy (2)
Postmarket research (237)
Preclinical (531)
Prostate cancer (16)
Psychedelics (3)
Radiopharmaceuticals (27)
Rare diseases (42)
Real estate (215)
Recruiting (3)
Regulatory (1793)
Reports (7)
Research institute (142)
Resumes & cover letters (4)
Rett syndrome (1)
RSV (4)
Schizophrenia (14)
Series A (4)
Series B (2)
Service/supplier (1)
Sickle cell disease (7)
Special edition (2)
Spinal muscular atrophy (18)
Sponsored (1)
Startups (112)
State (1)
Stomach cancer (1)
Vaccines (39)
Weight loss (10)
Women's health (1)
Worklife (1)
Date
Today (50)
Last 7 days (265)
Last 30 days (554)
Last 365 days (4523)
2025 (1742)
2024 (4869)
2023 (5331)
2022 (7551)
2021 (6430)
2020 (6114)
2019 (5152)
2018 (3742)
2017 (3562)
2016 (2558)
2015 (3514)
2014 (2237)
2013 (1630)
2012 (1701)
2011 (1897)
2010 (1779)
Location
Africa (52)
Alabama (3)
Alaska (1)
Arizona (15)
Arkansas (1)
Asia (3644)
Australia (428)
California (909)
Canada (252)
China (58)
Colorado (62)
Connecticut (64)
Delaware (32)
Europe (10582)
Florida (164)
Georgia (22)
Idaho (5)
Illinois (58)
India (4)
Indiana (48)
Japan (18)
Kansas (10)
Kentucky (1)
Louisiana (5)
Maine (7)
Maryland (107)
Massachusetts (603)
Michigan (52)
Minnesota (58)
Missouri (9)
Montana (3)
Nevada (11)
New Hampshire (9)
New Jersey (296)
New Mexico (5)
New York (257)
North Carolina (95)
North Dakota (1)
Northern California (465)
Ohio (21)
Oklahoma (1)
Oregon (1)
Pennsylvania (212)
Rhode Island (1)
South America (82)
South Carolina (1)
Southern California (319)
Tennessee (7)
Texas (94)
United States (3324)
Utah (41)
Virginia (10)
Washington D.C. (4)
Washington State (102)
West Virginia (1)
Wisconsin (5)
69,447 Results for "71".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Cybin’s Small Depression Study Shows 71% Remission Rate
Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month milestone.
November 18, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Global Telmisartan Market to Surpass USD 5.71 Bn by 2032
April 14, 2025
·
1 min read
Press Releases
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
May 2, 2025
·
5 min read
Press Releases
Automated Microbiology Market Size to Reach USD 21.71 Billion By 2034
February 28, 2025
·
1 min read
Press Releases
Lung Cancer Therapeutics Market Size to Reach USD 71.30 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
Breast Cancer Diagnostics Market Size to Attain USD 40.71 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Clinical Trials Support Services Market Size to Reach USD 53.71 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
Stablepharma Secures €2.5m EIC Accelerator Grant, Recognised Among Europe’s Top 71 Innovators
February 19, 2025
·
2 min read
Press Releases
MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share
January 20, 2025
·
1 min read
Press Releases
CRISPR Genomic Cure Market Growing Assessment to Reach USD 11.71 Billion by 2030
January 16, 2025
·
1 min read
1 of 6,945
Next
